Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Insulet secures $22mm in financing

Executive Summary

Insulet (disposable insulin delivery system) raised $22mm in its second round, which was co-led by new investors Pequot Ventures and Oakwood Medical Investors. Other contributors included Versant Ventures, Schroder Ventures Life Sciences, and returning investor, Prism Venture Partners. Insulet's total financing to date is $34mm.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
      • Transdermal
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies